ZANGHI', AURORA
ZANGHI', AURORA
Dipartimento di Scienze Mediche e Chirurgiche
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
2016-01-01 D'Amico, E; Patti, Francesco; Zanghì, A; Zappia, Mario
An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience
2024-01-01 Zanghi', A; Di Filippo, Ps; Avolio, C; D'Amico, E
An update on the safety of treating relapsing-remitting multiple sclerosis
2019-01-01 Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study
2019-01-01 D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Zappia, Mario; Patti, Francesco
Can new chemical therapies improve the management of multiple sclerosis in children?
2017-01-01 D'Amico, E; Zanghì, A; Patti, Francesco
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
2019-01-01 D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
2018-01-01 D'Amico, Emanuele; Zanghì, Aurora; Callari, Graziella; Borriello, Giovanna; Gallo, Antonio; Graziano, Giusi; Valentino, Paola; Buccafusca, Maria; Cottone, Salvatore; Salemi, Giuseppe; Ragonese, Paolo; Bossio, Roberto Bruno; Docimo, Renato; Grimaldi, Luigi Maria Edoardo; Pozzilli, Carlo; Tedeschi, Gioacchino; Zappia, Mario; Patti, Francesco
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis
2020-01-01 D'Amico, E.; Zanghi, A.; Sciandra, M.; Lanzillo, R.; Callari, G.; Cortese, A.; Lus, G.; Lucchini, M.; Buccafusca, M.; Bonavita, S.; Gallo, A.; Curti, E.; Gajofatto, A.; Signoriello, E.; Bisecco, A.; Gobbin, F.; Ferro, M. T.; Ferrazzano, G.; Sparaco, M.; Valentino, P.; Mirabella, M.; Granella, F.; Bresciamorra, V.; Grimaldi, L. M. E.; Patti, F.; Borriello, G.; Grossi, P.; Carotenuto, A.; Siena, E.; Tsantes, E.; Abbadessa, G. M.; Chisari, C. G.
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience
2019-01-01 D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F.
Disease trajectory in secondary progressive multiple sclerosis: a ten years follow-up study
2016-01-01 D'Amico, E; Zanghi, A; Lo Fermo, S; Zappia, M; Patti, F
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
2022-01-01 Zanghì, A; Avolio, C; Hartung, Hp; D'Amico, E
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
2019-01-01 D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Fermo, Salvatore Lo; Toscano, Simona; Arena, Sebastiano; Patti, Francesco; Zappia, Mario
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
2021-01-01 Zanghì, A; Gallo, A; Avolio, C; Capuano, R; Lucchini, M; Petracca, M; Bonavita, S; Lanzillo, R; Ferraro, D; Curti, E; Buccafusca, M; Callari, G; Barone, S; Pontillo, G; Abbadessa, G; Di Francescantonio, V; Signoriello, E; Lus, G; Sola, P; Granella, F; Valentino, P; Mirabella, M; Patti, F; D'Amico, E.; D'Amico, Emanuele
Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
2021-01-01 Zanghi, A.; D'Amico, E.; Lo Fermo, S.; Patti, F.
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study
2021-01-01 Zanghì, A; Avolio, C; Amato, Mp; Filippi, M; Trojano, M; Patti, F; D'Amico, E; Italian MS registry, Study.; D'Amico, Emanuele
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
2020-01-01 D'Amico, Emanuele; Zanghì, Aurora; Burgio, Giovanni; Chisari, Clara Grazia; Condorelli, Rosita Angela; La Vignera, Sandro; Calogero, Aldo Eugenio; Patti, Francesco
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
2022-01-01 D'Amico, E.; Zanghi, Aurora.; Parrinello, N. L.; Romano, A.; Palumbo, G. A.; Chisari, C. G.; Toscano, S.; Raimondo, F. D.; Zappia, M.; Patti, F.
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS
2022-01-01 D’Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo; Hartung, Hans-Peter
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment
2020-01-01 Zanghi, A.; D'Amico, E.; Patti, F.
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
2021-01-01 D'Amico, E.; Zanghi, A.; Romeo, M.; Cocco, E.; Maniscalco, G. T.; Brescia Morra, V.; Paolicelli, D.; De Luca, G.; Galgani, S.; Amato, M. P.; Salemi, G.; Inglese, M.; Confalonieri, P. A.; Lus, G.; Avolio, C.; Gallo, A.; Vianello, M.; Onofrj, M.; Filippi, M.; Trojano, M.; Patti, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives | 1-gen-2016 | D'Amico, E; Patti, Francesco; Zanghì, A; Zappia, Mario | |
An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience | 1-gen-2024 | Zanghi', A; Di Filippo, Ps; Avolio, C; D'Amico, E | |
An update on the safety of treating relapsing-remitting multiple sclerosis | 1-gen-2019 | Chisari, Clara G; Toscano, Simona; D'Amico, Emanuele; Lo Fermo, Salvatore; Zanghì, Aurora; Arena, Sebastiano; Zappia, Mario; Patti, Francesco | |
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study | 1-gen-2019 | D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Zappia, Mario; Patti, Francesco | |
Can new chemical therapies improve the management of multiple sclerosis in children? | 1-gen-2017 | D'Amico, E; Zanghì, A; Patti, Francesco | |
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort | 1-gen-2019 | D'Amico, Emanuele; Chisari, Clara G.; Arena, Sebastiano; Zanghì, Aurora; Toscano, Simona; Lo Fermo, Salvatore; Maimone, Davide; Castaing, Marine; Sciacca, Salvatore; Zappia, Mario; Patti, Francesco | |
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience | 1-gen-2018 | D'Amico, Emanuele; Zanghì, Aurora; Callari, Graziella; Borriello, Giovanna; Gallo, Antonio; Graziano, Giusi; Valentino, Paola; Buccafusca, Maria; Cottone, Salvatore; Salemi, Giuseppe; Ragonese, Paolo; Bossio, Roberto Bruno; Docimo, Renato; Grimaldi, Luigi Maria Edoardo; Pozzilli, Carlo; Tedeschi, Gioacchino; Zappia, Mario; Patti, Francesco | |
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis | 1-gen-2020 | D'Amico, E.; Zanghi, A.; Sciandra, M.; Lanzillo, R.; Callari, G.; Cortese, A.; Lus, G.; Lucchini, M.; Buccafusca, M.; Bonavita, S.; Gallo, A.; Curti, E.; Gajofatto, A.; Signoriello, E.; Bisecco, A.; Gobbin, F.; Ferro, M. T.; Ferrazzano, G.; Sparaco, M.; Valentino, P.; Mirabella, M.; Granella, F.; Bresciamorra, V.; Grimaldi, L. M. E.; Patti, F.; Borriello, G.; Grossi, P.; Carotenuto, A.; Siena, E.; Tsantes, E.; Abbadessa, G. M.; Chisari, C. G. | |
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience | 1-gen-2019 | D’Amico, E.; Zanghì, A.; Sciandra, M.; Borriello, G.; Callari, G.; Gallo, A.; Salemi, G.; Cottone, S.; Buccafusca, M.; Valentino, P.; Bossio, R. B.; Grimaldi, L. M. E.; Pozzilli, C.; Tedeschi, G.; Zappia, M.; Patti, F. | |
Disease trajectory in secondary progressive multiple sclerosis: a ten years follow-up study | 1-gen-2016 | D'Amico, E; Zanghi, A; Lo Fermo, S; Zappia, M; Patti, F | |
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications | 1-gen-2022 | Zanghì, A; Avolio, C; Hartung, Hp; D'Amico, E | |
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience | 1-gen-2019 | D'Amico, Emanuele; Zanghì, Aurora; Chisari, Clara Grazia; Fermo, Salvatore Lo; Toscano, Simona; Arena, Sebastiano; Patti, Francesco; Zappia, Mario | |
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study | 1-gen-2021 | Zanghì, A; Gallo, A; Avolio, C; Capuano, R; Lucchini, M; Petracca, M; Bonavita, S; Lanzillo, R; Ferraro, D; Curti, E; Buccafusca, M; Callari, G; Barone, S; Pontillo, G; Abbadessa, G; Di Francescantonio, V; Signoriello, E; Lus, G; Sola, P; Granella, F; Valentino, P; Mirabella, M; Patti, F; D'Amico, E.; D'Amico, Emanuele | |
Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study | 1-gen-2021 | Zanghi, A.; D'Amico, E.; Lo Fermo, S.; Patti, F. | |
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study | 1-gen-2021 | Zanghì, A; Avolio, C; Amato, Mp; Filippi, M; Trojano, M; Patti, F; D'Amico, E; Italian MS registry, Study.; D'Amico, Emanuele | |
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study | 1-gen-2020 | D'Amico, Emanuele; Zanghì, Aurora; Burgio, Giovanni; Chisari, Clara Grazia; Condorelli, Rosita Angela; La Vignera, Sandro; Calogero, Aldo Eugenio; Patti, Francesco | |
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis | 1-gen-2022 | D'Amico, E.; Zanghi, Aurora.; Parrinello, N. L.; Romano, A.; Palumbo, G. A.; Chisari, C. G.; Toscano, S.; Raimondo, F. D.; Zappia, M.; Patti, F. | |
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS | 1-gen-2022 | D’Amico, Emanuele; Zanghi', Aurora; Avolio, Carlo; Hartung, Hans-Peter | |
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment | 1-gen-2020 | Zanghi, A.; D'Amico, E.; Patti, F. | |
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register | 1-gen-2021 | D'Amico, E.; Zanghi, A.; Romeo, M.; Cocco, E.; Maniscalco, G. T.; Brescia Morra, V.; Paolicelli, D.; De Luca, G.; Galgani, S.; Amato, M. P.; Salemi, G.; Inglese, M.; Confalonieri, P. A.; Lus, G.; Avolio, C.; Gallo, A.; Vianello, M.; Onofrj, M.; Filippi, M.; Trojano, M.; Patti, F. |